Today: 17 May 2026
Verizon stock slips as Frontier deal nears the finish line after California OK
16 January 2026
1 min read

Verizon stock slips as Frontier deal nears the finish line after California OK

NEW YORK, Jan 16, 2026, 15:00 EST — Regular session

  • Verizon shares slip as investors weigh the Frontier acquisition, set to close next week
  • California regulators approved the deal, imposing conditions related to broadband expansion and affordability
  • A new network outage and pledged customer credits put service reliability under the spotlight as earnings approach later this month

Shares of Verizon Communications slipped roughly 0.7% to $39.08 in Friday afternoon trading. The drop came after California regulators gave the green light to Verizon’s $20 billion acquisition of Frontier Communications, removing the final big obstacle before the deal wraps up next week.

Verizon secured the green light as it aims to expand its fiber network and boost sales of bundled wireless and home internet packages. This move could redefine its growth trajectory, addressing investor calls for more reliable cash flow from heavily indebted telecom firms.

The broader market edged up amid volatile trading before the long weekend, with attention fixed on deal news and upcoming earnings instead of a strong risk-on rally.

New Street Policy analyst Blair Levin described the California decision as “imminent” and noted that Verizon “got nearly everything that we thought material” on key terms, despite not winning every issue. Fierce Wireless

The company just wrapped up a 10-hour wireless outage this week, which knocked out calls, texts, and data for hundreds of thousands of users. The disruption caught regulators’ eyes and pushed Verizon to offer account credits.

Verizon’s $20 credit requires customers to claim it via their accounts. The company hasn’t revealed the cause of the disruption or the number of customers impacted, Investopedia reports.

Telecom shares showed mixed moves, with AT&T slipping roughly 0.9%, while T-Mobile dropped over 2%. Investors grappled with concerns about rising competitive pressure and hefty network investment costs.

Frontier shares saw little movement as the deal is set to halt trading in the target’s stock before its scheduled delisting post-close.

The downside is clear: California’s deal terms come with compliance and buildout demands. Plus, any extra scrutiny from the outage could drive up costs, tighten oversight, or distract management as Verizon works to fold in a major fiber operation.

Key upcoming events include the anticipated deal closure on Jan. 20 and Verizon’s Q4 earnings release on Jan. 30. Investors will be keen to hear updates on financing, integration strategies, and forecasts for cash flow and capital expenditures.

Traders face a narrow window: nail the closing, then focus shifts to guidance — and if Verizon can stop outages from dominating the news again.

Stock Market Today

  • Aquestive Therapeutics Reports Strong Q1 Results, Analysts Maintain 2026 Forecasts
    May 16, 2026, 8:17 PM EDT. Aquestive Therapeutics (NASDAQ:AQST) posted strong first-quarter results with revenues of $14 million, surpassing analyst expectations by 33%, and smaller-than-expected losses of $0.07 per share. Despite the upbeat quarter, analysts forecast a 3.6% revenue decline in 2026 to $48.4 million and a 15% decrease in losses to $0.47 per share. The consensus price target remains steady at $8.89, suggesting the stock is trading in line with expectations amid continuing losses. Revenue growth is expected to slow significantly compared to the past five years, lagging behind an 8% annual growth forecast for the wider industry. Investors face mixed views on valuation, with targets ranging from $6.00 to $11.00 per share.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Dow dips from record zone as chip bounce meets Fed succession chatter
Previous Story

Dow dips from record zone as chip bounce meets Fed succession chatter

Google stock price: Alphabet Class C (GOOG) slips after-hours on data-sharing court fight — here’s what’s next
Next Story

Google stock price: Alphabet Class C (GOOG) slips after-hours on data-sharing court fight — here’s what’s next

Go toTop